Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

Its primary role is to manage your body’s natural sleep-wake cycle. People with low melatonin may have trouble falling or staying asleep. Alzheimer’s disease is a progressive neurodegenerative ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... Alzheimer's Treatment One Step ...

Half of those with hypothyroidism aren’t aware that they have it. The most common cause of hypothyroidism is Hashimoto’s disease. Natural treatments address lifestyle and environmental factors that ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

On the other hand, sleep problems like insomnia and sleep apnea can lead to serious health issues and even increase the risk ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

Amyloid-related imaging abnormalities are the most impactful adverse effect of anti-amyloid-β immunotherapies. Here, the authors review the detection, underlying mechanisms and clinical ...